Your session is about to expire
← Back to Search
Resistant Starch for Colon Cancer
Study Summary
This trial will test whether a high-dose soluble fiber supplement, given as a drink, can reduce the Ki67 proliferative colonic mucosal biomarkers of cancer risk in Alaska native people, who have the highest recorded incidence and death rate from colon cancer in the world.
- Colon Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the target demographic of this trial exceeding 25 years?
"The minimum age of admission for this particular medical study is 40 years old, with the maximum set at 70."
Are there any vacancies in this clinical trial for participants?
"The clinical trial is currently recruiting and was published on December 11th, 2017; the information posted online has been recently updated as of February 8th 2021."
How many participants are currently being evaluated in this clinical experiment?
"Affirmative. Upon inspection of the information provided on clinicaltrials.gov, it is evident that this medical trial began recruitment in December 2017 and was recently updated in February 2022. The study requires 60 participants between two appointed sites."
May I partake in this clinical investigation?
"This clinical trial is recruiting 60 colon cancer patients aged between 40 and 70. To be accepted, applicants must be in a healthy gastrointestinal state with body mass index ranging from 18-40 Kg/m2. Previous studies have found no difference in responses to fibre diets amongst those of various weights including the overweight or obese. Those who had noncancerous polyps removed previously are also eligible for this trial, as well as Alaska Native individuals enrolled in their Tribal Health System program."
Share this study with friends
Copy Link
Messenger